High Seroconversion Rates in Trypanosoma Cruzi Chronic Infection Treated with Benznidazole in People Under 16 Years in Guatemala

Hdl Handle:
http://hdl.handle.net/10144/618747
Title:
High Seroconversion Rates in Trypanosoma Cruzi Chronic Infection Treated with Benznidazole in People Under 16 Years in Guatemala
Authors:
Brum-Soares, L; Cubides, JC; Burgos, I; Monroy, C; Castillo, L; González, S; Viñas, PA; Urrutia, PP
Journal:
Revista da Sociedade Brasileira de Medicina Tropical
Abstract:
Geographical, epidemiological, and environmental differences associated with therapeutic response to Chagas etiological treatment have been previously discussed. This study describes high seroconversion rates 72 months after benznidazole treatment in patients under 16 years from a project implemented by Doctors without Borders in Guatemala.
Publisher:
Scielo Brasil
Issue Date:
1-Dec-2017
URI:
http://hdl.handle.net/10144/618747
DOI:
10.1590/0037-8682-0415-2016
PubMed ID:
28001219
Submitted date:
2017-01-11
Language:
en
ISSN:
1678-9849
Appears in Collections:
Other Diseases

Full metadata record

DC FieldValue Language
dc.contributor.authorBrum-Soares, Len
dc.contributor.authorCubides, JCen
dc.contributor.authorBurgos, Ien
dc.contributor.authorMonroy, Cen
dc.contributor.authorCastillo, Len
dc.contributor.authorGonzález, Sen
dc.contributor.authorViñas, PAen
dc.contributor.authorUrrutia, PPen
dc.date.accessioned2017-01-12T21:01:02Z-
dc.date.available2017-01-12T21:01:02Z-
dc.date.issued2017-12-01-
dc.date.submitted2017-01-11-
dc.identifier.citationHigh Seroconversion Rates in Trypanosoma Cruzi Chronic Infection Treated with Benznidazole in People Under 16 Years in Guatemala. 49 (6):721-727 Rev. Soc. Bras. Med. Trop.en
dc.identifier.issn1678-9849-
dc.identifier.pmid28001219-
dc.identifier.doi10.1590/0037-8682-0415-2016-
dc.identifier.urihttp://hdl.handle.net/10144/618747-
dc.description.abstractGeographical, epidemiological, and environmental differences associated with therapeutic response to Chagas etiological treatment have been previously discussed. This study describes high seroconversion rates 72 months after benznidazole treatment in patients under 16 years from a project implemented by Doctors without Borders in Guatemala.en
dc.language.isoenen
dc.publisherScielo Brasilen
dc.rightsArchived with thanks to Revista da Sociedade Brasileira de Medicina Tropicalen
dc.titleHigh Seroconversion Rates in Trypanosoma Cruzi Chronic Infection Treated with Benznidazole in People Under 16 Years in Guatemalaen
dc.identifier.journalRevista da Sociedade Brasileira de Medicina Tropicalen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.